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Abstract The median raphe region (MRR, which consist
of MR and paramedian raphe regions) plays a crucial role
in regulating cortical as well as subcortical network
activity and behavior, while its malfunctioning may lead
to disorders, such as schizophrenia, major depression, or
anxiety. Mouse MRR neurons are classically identified on
the basis of their serotonin (5-HT), vesicular glutamate
transporter type 3 (VGLUT3), and gamma-aminobutyric
acid (GABA) contents; however, the exact cellular com-
position of MRR regarding transmitter phenotypes is still
unknown. Using an unbiased stereological method, we
found that in the MR, 8.5 % of the neurons were 5-HT,
26 % were VGLUT3, and 12.8 % were 5-HT and
VGLUT3 positive; whereas 37.2 % of the neurons were
GABAergic, and 14.4 % were triple negative. In the
whole MRR, 2.1 % of the neurons were 5-HT, 7 % were
VGLUT3, and 3.6 % were 5-HT and VGLUT3 positive;
whereas 61 % of the neurons were GABAergic. Surpris-
ingly, 25.4 % of the neurons were triple negative and
were only positive for the neuronal marker NeuN. PET-1/
ePET-Cre transgenic mouse lines are widely used to
specifically manipulate only 5-HT containing neurons.
Interestingly, however, using the ePET-Cre transgenic
mice, we found that far more VGLUT3 positive cells
expressed ePET than 5-HT positive cells, and about 38 %
of the ePET cells contained only VGLUT3, while more
than 30 % of 5-HT cells were ePET negative. These data
should facilitate the reinterpretation of PET-1/ePET
related data in the literature and the identification of the
functional role of a putatively new type of triple-negative
neuron in the MRR.
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Introduction
The median raphe region (MRR) plays a fundamental role
in regulating cortical network activity, as well as subcor-
tical functions (Bohut 1997; Vertes et al. 1999). It partic-
ipates in several aspects of fear behavior, its lesion disrupts
the acquisition of conditioned fear memory, and it is
associated with specific subtypes of anxiety disorders
(Avanzi and Branda˜o 2001; Avanzi et al. 2003; Silva et al.
2004; Borelli et al. 2005; Dos Santos et al. 2005; Ohmura
et al. 2014; Peters et al. 2014; Zangrossi and Graeff 2014).
Its functional alterations may also lead to disorders, such as
schizophrenia or major depression (Aghajanian and Marek
2000; Hensler 2006). However, its precise cellular com-
position with regard to transmitter phenotypes is still
unknown.
The MRR is located in the midline of the brainstem and
consists of the MR and the paramedian raphe (PMR)
subregions. The MRR used to be known as a serotonergic
nucleus; however, several studies have already reported the
presence of non-serotonergic neurons (Gras et al. 2002;
Jackson et al. 2009) as well. Four cell populations can be
distinguished based on 5-HT, glutamate, and gamma-
aminobutyric acid (GABA) contents: (1) some neurons
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contain only 5-HT (serotonin only, SO cells); (2) others
show only vesicular glutamate transporter type 3 expres-
sion (VGLUT3 only, GO cells); (3) in the third group, both
molecules are detectable (serotonin and VGLUT3, SG
cells) (Fremeau et al. 2002; Shutoh et al. 2008); (4) while
the fourth group of cells is GABAergic (Stamp and Semba
1995; Serrats et al. 2003; Calizo et al. 2011) and only
contains vesicular GABA transporter (VGAT). No studies
have investigated the possible occurrence of cells that
would express none of these molecules or the ratios of
these four cell types in the MRR.
Serotonergic and glutamatergic MRR cells project
densely to several forebrain areas (Vertes et al. 1999;
Azmitia 1978; Ko¨hler 1982; Aznar et al. 2004; Varga et al.
2009). Serotonergic neurons desynchronize the hippocam-
pal activity and disrupt rhythmic discharge of septal
cholinergic and GABAergic neurons (Assaf and Miller
1978; Kinney et al. 1996; Vertes and Kocsis 1997).
VGLUT3 containing glutamatergic neurons suppress the
hippocampal ripple activity and disrupt memory consoli-
dation (Wang et al. 2015), and both of these cells can
innervate more forebrain areas simultaneously (Sz}onyi
et al. 2014). Although serotonergic and glutamatergic
neurons are frequently investigated, it is unknown how
many of them possess both transmitters.
Efforts to genetically identify and modify serotonergic
cells led to the discovery of the E26 transformation-
specific transcription factor PET-1 and its enhancer region
ePET (Hendricks et al. 1999). The generation of PET-1-
Cre and ePET-Cre transgenic mouse lines promised effi-
cient manipulation of the 5-HT containing neurons and
provided tools for numerous studies (Braz et al. 2009;
Hodges et al. 2009; Hawthorne et al. 2010; Liu et al.
2010; Depuy et al. 2011, 2013; Spaethling et al. 2014;
Wang et al. 2015).
In this study, we investigated the number of cells of
different cell populations in the MRR. In the whole MRR,
2.1 % of the neurons were 5-HT, 7 % were VGLUT3,
and 3.6 % were 5-HT and VGLUT3 positive; whereas
61 % of the neurons were GABAergic. Surprisingly,
25.4 % of the MRR neurons were only positive for the
neuronal marker NeuN and were negative for 5-HT,
VGLUT3, and VGAT, and because of several reasons
detailed below, these cells are highly unlikely to be false
negative. Furthermore, using one specific commonly used
ePET-Cre transgenic mouse line (Jackson Laboratories),
we show that more than half of the SO neurons are
negative for ePET, and about 38 % of the ePET cells only
contain VGLUT3. Therefore, ePET is not specific to
serotonergic cells, since it is present in a portion of SO,
GO, SG cells, and also in some of the unidentified neu-
ronal population.
Materials and methods
Animals and perfusions
All experiments were performed in accordance with the
Institutional Ethical Codex and the Hungarian Act of
Animal Care and Experimentation guidelines, which are in
concert with the European Communities Council Directive
of September 22, 2010 (2010/63/EU). The Animal Care
and Experimentation Committee of the Institute of
Experimental Medicine of the Hungarian Academy of
Sciences and the Animal Health and Food Control Station,
Budapest, have also approved the experiments.
VGAT-IRES-Cre mice were crossed with Gt(RO-
SA)26Sor_CAG/ZsGreen1 or with Gt(ROSA)26Sor_CAG/
tdTomato reporter mice, and ePET-IRES-Cre mice were
crossed with Gt(ROSA)26Sor_CAG/ZsGreen1 mice
(Jackson Laboratories). Their offspring showed genetically
coded specific fluorescent labeling in VGAT or ePET
expressing neurons. Scott et al. (2005) described in detail
the construction of this ePET-Cre mouse line. Three 42
days old male VGAT-ZsGreen1 offspring mice (named
GM1; GM2; and GM3), one 42 days old male VGAT-
tdTomato mouse (named GM4), one 42 days old male
C57BL/6J wild-type mouse (named WT), and three 49
days old male ePET-ZsGreen1 mice (named PM1; PM2;
and PM3) were used. For perfusion, mice were anes-
thetized with isoflurane, followed by intraperitoneal
injection of an anesthetic mixture (containing 8.3 mg/ml
ketamine, 1.7 mg/ml xylazine-hydrochloride, and 0.8 mg/
ml promethazinium-chloride) to achieve deep anesthesia.
Then, mice were transcardially perfused first with PBS
(0.9 % NaCl in 0.1 M phosphate buffer) solution for 2 min,
followed by 4 % paraformaldehyde for 40 min, and finally
with 0.1 M phosphate buffer (PB) for 10 min.
Fluorescent immunohistochemistry
After perfusion of mice and removal of their brains from
the skull, coronal sections were cut on a Leica VT1200S
vibratome at 60 lm from the whole MRR and collected in
stereological order into eight vials. This was followed by
washing out the fixative in 0.1 M (PB) for 1 h. Then, the
sections were cryoprotected sequentially in 10 % (over-
night) and 30 % (2 h) sucrose in PB and freeze–thawed
five times over liquid nitrogen. This was followed by
several washing in 0.1 M PB (3 9 10 min) and tris-buf-
fered saline solution (TBS, 3 9 10 min). Then, sections
were incubated in TBS containing 1 % human serum
albumin, 0.1 % TritonTM X-100, and 700 lg/ml Digitonin
(all from Sigma-Aldrich) for 1 h to achieve better
penetration.
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Vials were separated into two groups (even and odd
sections) that were used for experiment type A and B,
respectively (Table 2). Even-numbered sections were used
to demonstrate the ratios between the 5-HT and/or
VGLUT3 positive neurons, while odd-numbered sections
were used for determining the number of other neurons.
Antibodies
Table 1 summarizes information about the primary and
secondary antibodies. Previously, we extensively tested the
rabbit anti-VGLUT3 antibody in experiments using
VGLUT3 knock out animals (Sz}onyi et al. 2014).
Immunostaining of VGLUT3 in raphe neurons was also
tested by others (Mintz and Scott 2006; Shutoh et al. 2008).
The mouse anti-NeuN antibody labels a neuron specific
DNA binding nuclear protein and is widely used to identify
neurons (Mullen et al. 1992). To increase the accuracy of
the measurements, we counted only the DAPI stained
nuclei of cells. The rat and rabbit anti-5-HT antibodies
were characterized before (Amilhon et al. 2010; Fox and
Deneris 2012), they labeled the same cells, and also labeled
the expected population of neurons, which further confirm
their specificity. In the experiment, where the expression
pattern of ePET was analyzed, we found a mismatch
between ePET and 5-HT expression. These surprising
results prompted us to test whether it is possible that some
cells only express the synthesizing enzyme of serotonin,
but the enzyme does not produce detectable levels of
serotonin. Therefore, we tested whether all cells that are
positive for the 5-HT synthesizing enzyme, tryptophan
hydroxylase (TPH), are also positive for 5-HT. We colo-
calized rabbit anti-5-HT and mouse anti-TPH labeling
(Fig. 2). We found that all 160 examined TPH labeled cells
were also positive for 5-HT; consequently, 5-HT was
always detected in TPH expressing cells. This shows that
the sensitivity of 5-HT labeling cannot be responsible for
the lack of labeling in some cells, because cells that express its
synthesizing enzyme, TPH, always express detectable levels of
5-HT as well.
The antibody penetration into 60 lm-thick sections was
examined rigorously using confocal imaging, and was
found to be perfect even in the middle of the section. Se-
condary antibodies were extensively tested for possible
cross-reactivity with other primary or secondary antibod-
ies, but no cross-reactivity was found.
Confocal microscopy
Image stacks were recorded by using a Nikon A1R con-
focal laser-scanning system built on a Ti-E inverted
microscope with 0.45 NA CFI Super Plan Fluor ELWD
20XC Nikon objective and operated by NIS-Elements AR
4.3 software. Argon ion laser (457–514 nm, 40 mW),
yellow DPSS laser (561 nm, 20 mW), violet diode laser
(405 nm), and diode laser system (647 nm, 100 mW) were
used as excitation lasers with appropriate filters. Images
were acquired at a z-separation of 1 lm. Each section
plane was identified by using the Mouse Brain Atlas
(Paxinos and Franklin 2012).
Table 1 Antibody specifications
Raised against Raised in Protein cc. of
stock solution
Dilution Source Catalog number Lot number Characterized
VGLUT3 Rabbit 1 lg/ll 1:500 Synaptic Systems 135203 Szonyi et al. (2014)
NeuN Mouse 1 mg/ml 1:500 Chemicon MAB 377 LV 1359479 Mullen et al. (1992)
Serotonin Rat Not available 1:500 Merck Millipore MAB 352 2168248 Amilhon et al. (2010)
Serotonin Rabbit 25 lg/ml 1:10000 ImmunoStar 20080 1431001 Fox and Deneris (2012)
TPH Mouse 1:3000 Sigma-Aldrich T0678 Calizo et al. (2011)
Conjugated with Raised in Raised against Dilution Source Catalog number Molecule
Alexa 594 Donkey Mouse 1:500 Life technologies A-21203 Full IgG
Alexa 647 Chicken Rat 1:500 Life technologies A-21472 Full IgG
Alexa 647 Donkey Rabbit 1:500 Jackson immuno-
research
711-605-152 Full IgG
Cy3 Donkey Rabbit 1:500 Jackson immuno-
research
711-165-152 Full IgG
Alexa 488 Donkey Mouse 1:500 Life technologies A21206 Full IgG
Alexa 488 Donkey Rabbit 1:500 Life technologies A 21202 Full IgG
DAPI – – 1:10.000 Sigma-Aldrich D9564 –
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Stereology measurement
Unbiased design-based stereological measurements were
carried out using the optical fractionator method (Sterio
1984; Gundersen 1986; West and Slomianka 1991; Sch-
mitz and Hof 2005), which is based on the principle that
one can accurately define the number of cells in the vol-
ume of interest by counting them in a predetermined
fraction of the given volume (Dorph-Petersen et al. 2001).
To get the total cell numbers, the number of counted cells
is multiplied by the reciprocal of three different fractions:
section, area, and thickness sampling fractions (West and
Slomianka 1991). Using systematic random sampling in
each experiment, every second section of the MRR was
used; therefore, section sampling fraction was 0.5. In
mounted sections, cells were counted only within a frac-
tion of a predefined grid area. In the MR, this fraction was
152/402 lm in experiment type A and 152/802 lm in
experiment type B. In the PMR, this fraction was 102/
802 lm for both types of experiments. Finally, thickness
sampling fraction was about 15/28 lm, because the
average mounted section thickness was about 28 lm and
counting performed only in a 15-lm-high counting cube.
We used a guard zone of minimum 5 lm of tissue above
and below the counting cube; however, for maximum
accuracy, thickness sampling fractions were determined at
every sampling site. Cells were counted inside the
counting cubes or if they touched one of the inclusion
planes of the counting cubes. Using these parameters, we
directly identified the phenotype of about 13 % of the MR
neurons and altogether counted about 12,300 nuclei in
MRR in these animals. Cell counting was carried out in
Stereo Investigator 10.0 stereology software (MBF Bio-
science), while cells were identified parallel using NIS-
Elements AR 4.2 software.
Results
Cell types of the MRR
Using immunohistochemistry combined with stereological
methods, we identified ten different types of neuronal
phenotypes in the MRR. We used three kinds of genetically
modified mouse strains and one wild-type mouse. We
carried out two types of experiments, because we could use
a maximum of four different fluorescent channels per
experiment. In experiment type A, we focused on the
identification of SO, GO, SG, VGAT, or ePET positive
cells, while in experiment type B, we primarily focused on
NeuN positive neurons that were negative for all other
labeling (see Table 2). To label 5-HT, VGLUT3, and
NeuN, we used immunohistochemistry; to stain the nuclei,
we performed DAPI histochemistry and we used geneti-
cally expressed fluorescent markers for the visualization of
VGAT and ePET. Using an unbiased stereological method,
the combination of different mice and two types of
experiments allowed the estimation of the absolute number
of different cells in the MRR. The general labeling pattern
of neuronal markers distributed in the MRR as expected,
and neuronal markers could be clearly distinguished
(Figs. 1, 2, 3, 4). We found that the genetic background did
not have any effect on the estimated cell numbers.
In all mouse strains, genetically determined fluorescent
markers showed intensive expression in the soma of VGAT
or ePET containing neurons (Figs. 3a3–d3, 4a3, b3). Some
neurons expressed only these genetically determined mark-
ers: these are only VGAT positive (Fig. 3a3, c3, asterisk) or
only ePET positive cells (Fig. 4b3, asterisk). In experiment
type B, to determine the total number of neurons, we used
Neu-N staining (Fig. 3a1, c1), which labeled all neuronal
nuclei and with a lower intensity also the cytoplasm. Some
Table 2 Experiment types, primary and secondary antibody combinations, and animals from different mouse strains
Mice (genetic background) Experiment type A (here 5-HT and VGLUT3
cells could be distinguished, using different
fluorescent channels)
Experiment type B (here 5-HT and VGLUT3 cells could not
be distinguished, but other neurons could be detected in a
separate channel with NeuN)
GM1, GM2, GM3 (strain:
VGAT-IRES-Cre-ZsGreen)
PM1, PM2, PM3—tested
only with type A (strain:
ePet-ZsGreen)
WT—tested only with type
A (strain: C57BL/6J)
Rat anti-5-HT/Alexa 647
Rabbit anti-VGLUT3/Cy3
DAPI
Rat anti-5-HT/Alexa 647
Rabbit anti-VGLUT3/A647
Mouse anti-NeuN/Alexa 594
DAPI
GM4 (strain: VGAT-IRES-
Cre-tdTomato)
Rat anti-5-HT/Alexa 647
Rabbit anti-VGLUT3/Alexa 488
DAPI
Rat anti-5-HT/Alexa 647
Rabbit anti-VGLUT3/Alexa647
Mouse anti-NeuN/Alexa 488
DAPI
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cells were only NeuN positive, which were marked with
filled circle in Fig. 3. In experimental type B, 5-HT and/or
VGLUT3 positive cells were visualized in the same fluo-
rescent channel (Fig. 3a2, c2). Some cells were positive for
5-HT and/or VGLUT3 (filled square in Fig. 3), while some
were only NeuN positive or VGAT positive.
In experiment type A, 5-HT positive (Figs. 3b1, d1, 4a1,
b1) and VGLUT3 positive (Figs. 3b2, d2, 4a2, b2) cells
were visualized separately. Both of the markers showed
intensive labeling in the somata and axon terminals. In the
case of VGAT-Cre animals (Fig. 3), SO cells (filled circle),
GO cells (filled square), SG cells (empty circle), VGLUT3
and VGAT positive cells (empty square), and VGAT-
positive (GABAergic) cells could be differentiated. In the
case of ePET-Cre animals (Fig. 4), some SO cells
expressed ePET (filled circle), while some were ePET
negative (empty circle). Some GO cells were ePET positive
(filled square), while some were ePET negative (empty
square). Most SG cells were ePET positive (filled dia-
mond), but some were ePET negative (empty diamond). In
both types of experiment, we performed DAPI staining,
which labelled the nuclei in the blue fluorescent channel.
Stereological results are shown in Table 3 for MR and in
Table 4 for PMR and the whole MRR. Based on these data,
we calculated the ratios of the different cells types and
plotted all results in Fig. 5. Briefly, in the MR, we found
that only about 8.5 % of the neurons are SO cells, 26 % are
GO cells, and about 12.8 % are SG double positive cells;
whereas 37.2 % of the neurons are GABAergic, and
14.4 % of all MR neurons were triple negative for 5-HT,
VGLUT3, and VGAT. In the PMR, we found that only
6.4 % of all neurons expressed 5-HT and/or VGLUT3, but
these cells appeared only very close to the MR border,
which was defined according to the Mouse Brain Atlas
(Paxinos and Franklin 2012). 66.8 % of all PMR neurons
expressed VGAT, while 27.7 % of the neurons were triple
negative for 5-HT, VGLUT3, and VGAT. We never found
that colocalization between 5-HT and VGAT and colo-
calization between VGLUT3 and VGAT occurred only
very rarely (see Tables 3, 4; Fig. 5 for details).
The mouse MRR is a relatively small area. Dendritic
trees of cells in MR or PMR cross their putative borders as
well, making specific activation or deactivation of these
putative subregions even more difficult. In addition, sepa-
rate manipulation of the MR and PMR with optogenetic,
electrical, and/or pharmacological tools would currently be
a considerable challenge, if possible at all. Although
genetic tagging can be used to selectively target a
Fig. 1 Fluorescent micrographs show representative MRR sections
with 5-HT labeling. Subregions (MR and PMR) are defined based on
the Mouse Brain Atlas (Paxinos and Franklin 2012). Position of the
coronal section is indicated in each image, relative to the Bregma.
Scale bar 100 lm for all images
Fig. 2 Confocal laser scanning images (a–c) show 100 % colocalization between the labeling of 5-HT and its synthesizing enzyme, TPH, in
representative MR neurons (asterisk). Scale bar 50 lm for all images
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subpopulation of neurons, available methods would still
manipulate cell in both MR and PMR together. Therefore,
separation of MR and PMR is impossible even with
optogenetic methods. Therefore, we calculated the number
of cells for the whole MRR as well. We found that 13.5 %
of the MRR neurons contained 5-HT and/or VGLUT3,
while 61.8 % expressed VGAT, and 25.4 % belongs to the
unidentified cell type (see Tables 3, 4; Fig. 5 for details).
Distribution of ePET positive cells in the MRR
Previously, the PET-1 enhancer region, ePET, was thought
to be expressed exclusively in serotonergic cells. However,
we found a mismatch between ePET and 5-HT expression
in MRR, as shown in Figs. 4, 5 and Tables 3, 4. We also
found triple-negative NeuN positive neurons that were
labeled with ePET. Although, in this experimental design,
colocalization between the genetic markers (ePET and
VGAT) is not possible, it is highly unlikely that these
markers would colocalize, because ePET positive cells are
mostly localized in MR, and most GABAergic cells are in
the PMR. In addition, SO and SG cells that are partly ePET
positive were never GABAergic. Furthermore, generally,
excitatory and inhibitory neurons derive from different cell
lines; therefore, it is highly unlikely that ePET would be
localized in GABAergic cells as well. Therefore, we clas-
sified triple-negative and ePET positive cells as VGAT
negative. Results clearly show that ePET is partially
Fig. 3 Confocal laser scanning images used for stereological mea-
surement of different cell types of MRR in VGAT-IRES-Cre-ZsGreen
(a, b) and VGAT-IRES-Cre-tdTomato mice (c, d). In both strains,
genetically determined fluorescent markers labeling VGAT are shown
in green in a3–d3. Nuclei were always labeled with DAPI (blue). In
‘‘experiment type B’’ (a1–a4; c1–c4), neurons were identified with
Neu-N staining (red), while 5-HT and/or VGLUT3 positive cells were
visualized in the same fluorescent channel (white). Some cells were
only NeuN positive (filled circles), and some were positive for 5-HT
and/or VGLUT3 (filled square); while some of them only VGAT
positive (asterisk). In ‘‘experiment type A’’ (b1–b4; d1–d4), 5-HT
positive (white) and VGLUT3 positive (red) cells were visualized
separately. SO cells (filled circle), GO cells (filled square), SG cells
(empty circle), VGLUT3 and VGAT positive cells (empty square),
and only VGAT-positive cells (asterisk) could be differentiated. Scale
bar 50 lm for all images
Brain Struct Funct
123
expressed in four different populations of neurons
(Table 3; Fig. 5).
Because the ‘‘border’’ between MR and PMR is artifi-
cial, we have all reason to believe that all SO cells in MRR
belong to the same neuronal population, regardless of their
localization in MR or PMR, and the same is true for all
other cell types. Therefore, the ratio of ePET positive cells
in the PMR was calculated based on the ratios found in
MR. However, to further confirm that ePET positive cells
indeed comprise the same cell types at a similar distribu-
tion in the PMR, we defined the phenotype of the counted
ePET positive cells in the PMR in experimental type A of
one mouse. In that case, we used a semiquantitative
approach that allowed the testing of colocalization of other
Fig. 4 Confocal laser scanning images used for stereological mea-
surement of different cell types of MRR in ePET-IRES-Cre-ZsGreen
mice (a, b) in ‘‘experiment type A’’. ePET labeling is green, nuclear
DAPI labeling is blue, while 5-HT (white) and VGLUT3 (red)
positive cells were visualized separately. Some SO cells express ePET
(filled circle), while some are ePET negative (empty circle). Some GO
cells were ePET positive (filled square), while some are ePET
negative (empty square). Most SG cells are ePET positive (filled
diamond), but some are ePET negative (empty diamond). Some cells
expressed only ePET without any other labeling (asterisk). Scale bar
50 lm for all images
Table 3 Number of cells in median raphe
The number of cells in median raphe in eight mice
Labelled cell types GM1 GM2 GM3 GM4 WT PM1 PM2 PM3 Mean
Non-neuronal cells, only DAPI positive 11269 10449 10672 11928 – – – – 11079
All neurons (calculated, using all mice, from the mean number of all labelled neurons) 8160
All 5-HT positive cells, without VGLUT3 labeling—abbreviated as
‘‘SO’’
1310 515 573 662 640 807 351 697 695
And from these, ePET positive cells are: – – – – – 380 240 378 333
All VGLUT3 positive cells, without 5-HT labeling—abbreviated as
‘‘GO’’
1840 2078 2209 2055 2041 2209 2591 1957 2123
And from these, ePET positive cells are: – – – – – 906 886 959 917
All 5-HT and VGLUT3 double positive cells—abbreviated as ‘‘SG’’ 627 890 904 940 1408 1427 1014 1126 1042
And from these, ePET positive cells are: – – – – – 1002 705 891 866
All 5-HT and/or VGLUT3positive cells 3655 3450 3426 3620 4089 4862 3957 3780 3855
All VGAT positive cells, without 5-HT and VGLUT3 labeling 3105 3190 2619 3222 – – – – 3034
All VGAT and VGLUT3 double positive cells, without 5-HT labeling 35 149 93 65 – – – – 86
All NeuN positive cells (triple negative), without 5-HT, VGLUT3 and
VGAT labeling
597 712 1632 1782 – – – – 910
All ePET positive cells, without 5-HT and/or VGLUT3 labeling – – – – – 68 451 296 271
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markers with ePET positive cell on a larger number of
cells. We collected ePET positive cells in PMR from a
representative series of sections (a sample size was 425
ePET? cells) in experimental type A. This was more
optimal in this case, because ePET positive cells are rare in
the PMR, and testing with the fully quantitative method
would have provided an unacceptably small sample. The
result is shown in Fig. 5d lower pie chart. This proportion
is very similar to the ratio in the MR (Fig. 5d upper pie
chart) that further confirms that these regions contain the
same type of cells.
Discussion
Using an unbiased stereological method, first, we estimated
the average numbers of different cell types of the mouse
MR and PMR areas. Second, we found that about a quarter
of the neurons are negative for 5-HT, VGLUT3, and
VGAT, which indicates the existence of a so far unrecog-
nized cell population. Third, we found that ePET is not
specific for 5-HT, because it is not present in all SO neu-
rons, and it is expressed in GO and triple-negative neurons
as well.
Ratios of cell types in MR and PMR
MRR is a widely investigated brain area, and several
physiological experimental manipulations (excitation,
inhibition or lesions) target the whole MRR. The physio-
logical role of individual cell populations could be studied
using optogenetic manipulation of cells with certain neu-
rochemical phenotypes; however, even this method cannot
be cell type specific, because MRR neurons form neuro-
chemically overlapping cell populations that hamper their
separate investigation. Although intersectional genetics
might help to separate these cells in the future, it is
important to know their ratios; otherwise, even intersec-
tional genetic experiments may be misinterpreted. In
addition, our results can help to define the absolute number
of cells that are modulated in optogenetic experiments.
5-HT and VGLUT3 neurons are abundant in the center
of the MRR, and they are getting gradually less and less
abundant outward from the center, and the steepness of the
decrease in abundance is variable between mice. Therefore,
there is no way to unbiasedly draw a border between MR/
PMR based on staining pattern. Dendritic trees of cells in
MR or PMR cross their putative borders as well making
specific activation or deactivation of these putative subre-
gions even more difficult, if possible at all. The mouse
MRR is relatively small; therefore, even from the practical
point of view, the separation of the MR and PMR may also
seems to be less useful, because most types of experimental
interventions would affect both MR and PMR in mice.
These subregions contain the same types of cells, and
during experiments using optical fibers the lateral and the
conical light spread is about 500–1000 lm from the optical
fiber tip (Adamantidis et al. 2007; Yizhar et al. 2011),
which would affect the whole volume of median raphe
region; therefore, at least in mice, data for the whole MRR
seem to be more useful. However, because of historical
reasons and also to allow a certain level of comparison with
Table 4 Number of cells in paramedian raphe and median raphe region
The number of cells in paramedian raphe The number of
cells in MRR (sum
of the means of MR
and PMR cells)
Labelled cell types GM1 GM2 GM3 GM4 Mean
Non-neuronal cells, only DAPI positive 69924 59634 71573 71472 68151 79230
All neurons (calculated, using all mice, from the mean number of all labelled neurons) 39298 47458
All 5-HT positive cells, without VGLUT3 labeling—abbreviated as ‘‘SO’’ 264 0 795 221 320 1015
And from these, ePET positive cells (calculated based on the proportions in Fig. 5b) are: 153 486
All VGLUT3 positive cells, without 5-HT labeling—abbreviated as ‘‘GO’’ 751 1143 2094 899 1222 3344
And from these, ePET positive cells (calculated based on the proportions in Fig. 5b) are: 528 1445
All 5-HT and VGLUT3 double positive cells—abbreviated as ‘‘SG’’ 1438 217 555 460 668 1710
And from these, ePET positive cells (calculated based on the proportions in Fig. 5b) are: 555 1421
All 5-HT and/or VGLUT3positive cells 2514 1535 3013 1785 2212 6067
All VGAT positive cells, without 5-HT and VGLUT3 labeling 33486 25728 25035 19445 25924 28958
All VGAT and VGLUT3 double positive cells, without 5-HT labeling 244 578 234 130 297 383
All NeuN positive cells(triple-negative cells), without 5-HT, VGLUT3 and
VGAT labeling
9017 8646 11991 13820 10710 12049
All ePET positive cells, without 5-HT and/or VGLUT3 labeling (calculated based on the proportions in Fig. 5b) 159 430
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other species, we analyzed MR and PMR separately as
well, for which the only unbiased and reproducible method
was to use the stereotaxic Mouse Brain Atlas as reference
(Paxinos and Franklin 2012).
Interestingly, based on these criteria, more than a third
of the 5-HT and/or VGLUT3 containing neurons are in the
PMR—mostly closer to the MR border. We found that
about half of the serotonergic cells contained VGLUT3,
whereas a third of the VGLUT3 neurons were positive for
5-HT as well. It is important to note that, while the MRR
contains about 47,500 neurons, only about 13 % of them
are investigated regularly, because these 5-HT and/or
VGLUT3 positive cells are known to project to forebrain
areas.
One-third of MR neurons and two-thirds of PMR neu-
rons are GABAergic, and these cells never contained 5-HT.
Fig. 5 Number of cells and ratios in the median raphe region. Using
original data presented in Tables 3, 4, these pie charts show
calculated results originating from eight mice. a Ratios between
neurons and non-neuronal cells in the MR, PMR, and MRR. b,
c Different neuron types and ePET expression in the MR and PMR,
respectively. d Distribution of 5-HT and VGLUT3 contents in ePET
expressing neurons in the MR and PMR. Ratios of PMR neurons were
defined with a semiquantitative method; therefore, the number of cells
is not shown, but could be calculated from the other pie charts.
e Summary pie chart about the whole MRR neurons
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Although it may seem insignificant, we found that about
0.8 % of MRR neurons showed VGAT and VGLUT3
double positivity. This type of colocalization is also known
in a population of hippocampal GABAergic interneuron
(Somogyi et al. 2004), but their connections and role in the
MRR is unknown.
The quarter of MRR neurons belong to an unknown
population
We found a previously unidentified cell population, which
constituted more than 25 % of the MRR neurons. This
group was triple negative for 5-HT, VGLUT3, and VGAT
labeling, and was positive only for the neuronal NeuN
staining.
These cells are highly unlikely to be false negative,
because: (1) they were just as numerous close to the section
surface, where no antibody penetration problems occur, (2)
they were surrounded by other strongly positive cells, also
indicating appropriate antibody penetration; furthermore,
(3) these triple-negative cells were distributed homoge-
neously in the tissue, which means that it is not due to
regional penetration differences. In addition, (4) about
28 % of neurons belong to this triple-negative population
also in the PMR, where SO, GO, and SG cells are rare, so
they are highly unlikely to be false negative of those
populations. (5) We proved that 5-HT can indeed label all
serotonergic cells, because all TPH positive cells were
5-HT positive. (6) Genetic labeling was always very strong,
and the specificity of genetically labeled VGAT expression
was extensively tested (Madisen et al. 1993; Vong et al.
2011).
This triple-negative cell type was completely over-
looked in the literature, because only SO, GO, SG, and
GABAergic neurons were investigated, and to the best of
our knowledge, these markers have never been investigated
in the same experiment. Triple-negative cells are unlikely
to be glutamatergic, because other vesicular glutamate
transporter (VGLUT1 or VGLUT2) positive cells have not
yet been shown in the MRR (Hioki et al. 2010).
Dopaminergic neurons of negligible density were observed
in the rat MRR (Jahanshahi et al. 2013), and although its
colocalization with 5-HT or VGLUT3 was not tested, tri-
ple-negative cells are much more abundant, therefore,
highly unlikely to be dopaminergic. In the MRR, most
neurokinin-1 receptor labeling did not colocalize with
VGLUT3 (Commons and Serock 2009), but other neurons
of the MRR were not tested. Somatostatin and galanin
positive neurons were also observed in the MRR (Araneda
et al. 1999), but their localization in VGLUT3 and/or all
5-HT positive cells was not tested. To the best of our
knowledge, so far, no other types of neurons were
identified in the MRR that could account for the amount of
this new triple-negative type of neuron.
Possible neurotransmitter phenotype plasticity of
5-HT and/or VGLUT3 containing neurons
Neurotransmitter phenotype plasticity has already been
described in several areas of the mammalian brain (Baudry
et al. 2010; Dulcis et al. 2013). For instance, during the
normal development (between P15 and P90), dopamine
neurons lose their VGLUT2 contents completely in ventral
tegmental area and substantia nigra (Be´rube´-Carrie`re et al.
2009). In the medial nucleus of the trapezoid body,
GABAergic neurons transiently release glutamate, and then
switch to glycine as a primary neurotransmitter (Demarque
and Spitzer 2012). Glutamatergic granule cells of the
dentate gyrus are initially GABAergic, and then express a
dual GABAergic/glutamatergic phenotype before becom-
ing purely glutamatergic, but they can transiently express a
GABAergic phenotype when a state of hyperexcitability is
induced in the adult rat (Gutie´rrez et al. 2003). Interest-
ingly, in the MRR in this study, the number of 5-HT and/or
VGLUT3 containing neurons shows high variability among
mice. Although their ages were similar, 5-HT could be
detected in more cells in mouse GM1 compared with GM2;
on the other hand, GM2 had more VGLUT3 positive GO
and GS cells. However, the total numbers of 5-HT and/or
VGLUT3 containing neurons are fairly stable among ani-
mals, which suggest that in some mice, serotonergic/glu-
tamatergic ratios would change without changing the total
number of main forebrain projection neurons: SO, GO, and
SG cells. These shifts in ratios are unlikely to be due to
technical reasons, because we used all sections of the MRR
and collected a large systematic random sample; therefore,
uneven or topographic cell distributions could not account
for this variability. We may hypothesize that these SO, GO,
and SG cells belong to the same neuronal population,
which can change its transmitter phenotype, as a function
of activity in MRR inputs. Other data also support this
hypothesis. First, ePET was expressed in all these three
types of neurons, and we found some triple-negative cells
that were also labeled with ePET, which may represent
either a transitional cell population or a developmental
side-branch. Second, VGLUT3 accelerates 5-HT trans-
mission at specific 5-HT terminals; its deletion decreased
5-HT tone in projection areas and decreased serotonin
autoreceptor-mediated transmission in raphe, further sug-
gesting a close cooperation of these transmitter systems in
the same cells (Amilhon et al. 2010). Third, a robust
change in serotonin content of raphe neurons has already
been detected between postnatal day 22 and 61 (Rind et al.
2000). Our mice (P42, P49) had slightly different housing
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environments; some of them had many littermates, and
others had less that may have caused a variation in regu-
lation of their MRR.
Expression of ePET is not restricted to serotonergic
neurons
A large body of the literature, partly summarized by
Deneris (2011), is based on the assumption that PET-1/
ePET can faithfully identify serotonergic neurons. PET-1
was identified as a key factor that triggers the appearance
of serotonergic phenotype (Hendricks et al. 1999). PET-1
was thought to play a role in the 5-HT neuron development
and is required for anxiety-like and aggressive behavior
(Hendricks et al. 2003). Based on those results, ePET (an
enhancer region upstream of mouse PET-1-transcribed
sequences) was identified and was thought to be a reliable
marker for serotonergic cells (Scott et al. 2005).
Using a commonly used ePET-Cre transgenic mouse
line that was described by Scott et al. (2005) and is now
supplied by Jackson Laboratories; here, we studied the
expression of ePET in different types of MRR neurons.
Surprisingly, ePET is expressed not only in SO cells, but in
GO and SG neurons as well. More than half of SO cells
showed a lack of ePET expression, while almost half of GO
neurons were also ePET positive. More than a tenth of all
ePET expressing neurons were negative for both 5-HT and
VGLUT3 labeling. In fact, a previous study has already
also shown that 5-HT positive neurons are present in the
raphe even in PET-1 knock-out mice, and they were esti-
mated to be about 20–30 % of the 5-HT neuron population
in wild-type mice (Kiyasova et al. 2011). PET-1-indepen-
dent and dependent serotonergic cells have been shown to
project to different brain areas (Kiyasova et al. 2011).
Furthermore, non-serotonergic neurons were also found to
be positive for PET-1 in several raphe nuclei (Pelosi et al.
2014).
Our results can be used to estimate the number and
ratios of modulated neurons in previous and future studies,
employing ePET/PET-1 transgenic mice, and facilitate the
reinterpretations of data in the literature.
Acknowledgments We thank Em}oke Sze´pne´ Simon, Katalin
Lengyel and Katalin Iva´nyi for the excellent technical assistance.
The authors wish to thank La´szlo´ Barna, the Nikon Microscopy
Center at IEM, Nikon Austria GmbH and Auro-Science Consulting
Ltd for kindly providing technical support for fluorescent micro-
scopy. This work was supported by the European Research Council
(Grant number ERC-2011-ADG-294313, SERRACO) and the
National Institutes of Health (Grant number NS030549). Ga´bor
Nyiri was supported by a Ja´nos Bolyai Research Scholarship.
Andra´s Sz}onyi was supported by the European Union and the State
of Hungary, cofinanced by the European Social Fund in the frame-
work of TA´MOP 4.2.4. A/1-11-1-2012-0001 ‘‘National Excellence
Program’’.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict
of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Adamantidis AR, Zhang F, Aravanis AM et al (2007) Neural
substrates of awakening probed with optogenetic control of
hypocretin neurons. Nature 450:420–424. doi:10.1038/
nature06310
Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia:
emerging role of glutamate mechanisms. Brain Res Rev
31:302–312
Amilhon B, Lepicard E, Renoir T et al (2010) VGLUT3 (vesicular
glutamate transporter type 3) contribution to the regulation of
serotonergic transmission and anxiety. J Neurosci 30:2198–2210.
doi:10.1523/JNEUROSCI.5196-09.2010
Araneda S, Gysling K, Calas A (1999) Raphe serotonergic neurons
projecting to the olfactory bulb contain galanin or somatostatin
but not neurotensin. Brain Res Bull 49:209–214. doi:10.1016/
S0361-9230(99)00055-6
Assaf SY, Miller JJ (1978) The role of a raphe serotonin system
in the control of septal unit activity and hippocampal desyn-
chronization. Neuroscience 3:539–550. doi:10.1016/0306-
4522(78)90018-0
Avanzi V, Branda˜o ML (2001) Activation of somatodendritic
5-HT1A autoreceptors in the median raphe nucleus disrupts
the contextual conditioning in rats. Behav Brain Res
126:175–184. doi:10.1016/S0166-4328(01)00254-6
Avanzi V, Silva RCB, Macedo CE, Branda˜o ML (2003) 5-HT
mechanisms of median raphe nucleus in the conditioned freezing
caused by light/foot-shock association. Physiol Behav
78:471–477. doi:10.1016/S0031-9384(03)00029-5
Azmitia CSM (1978) An Autoradiographic analysis of the differential
ascending projections of the dorsal and median raphe nuclei in
the rat. J Comp Neurol 3:641–667
Aznar S, Qian ZX, Knudsen GM (2004) Non-serotonergic dorsal and
median raphe projection onto parvalbumin- and calbindin-
containing neurons in hippocampus and septum. Neuroscience
124:573–581. doi:10.1016/j.neuroscience.2003.12.020
Baudry A, Mouillet-Richard S, Schneider B et al (2010) miR-16
targets the serotonin transporter: a new facet for adaptive
responses to antidepressants. Science 329:1537–1541. doi:10.
1126/science.1193692
Be´rube´-Carrie`re N, Riad M, Dal Bo G et al (2009) The dual
dopamine-glutamate phenotype of growing mesencephalic neu-
rons regresses in mature rat brain. J Comp Neurol 517:873–891.
doi:10.1002/cne.22194
Bohut M-C (1997) Serotonin receptors in cognitive behaviors. Cogn
Behav 7:243–254
Borelli KG, Ga´rgaro AC, Dos Santos JM, Branda˜o ML (2005) Effects
of inactivation of serotonergic neurons of the median raphe
nucleus on learning and performance of contextual fear condi-
tioning. Neurosci Lett 387:105–110. doi:10.1016/j.neulet.2005.
07.031
Brain Struct Funct
123
Braz JM, Enquist LW, Basbaum AI (2009) Inputs to serotonergic
neurons revealed by conditional viral transneuronal tracing.
J Comp Neurol 514:145–160. doi:10.1002/cne.22003
Calizo LH, Akanwa A, Ma X et al (2011) Raphe serotonin neurons
are not homogenous: electrophysiological, morphological and
neurochemical evidence. Neuropharmacology 61:524–543.
doi:10.1016/j.neuropharm.2011.04.008
Commons KG, Serock MR (2009) Coincidence of neurokinin 1
receptor with the vesicular glutamate transporter 3 (VGLUT3) in
the rat forebrain. Neurosci Lett 464:188–192. doi:10.1016/j.
neulet.2009.08.042
Demarque M, Spitzer NC (2012) Neurotransmitter phenotype plas-
ticity: an unexpected mechanism in the toolbox of network
activity homeostasis. Dev Neurobiol 29:997–1003. doi:10.1016/
j.biotechadv.2011.08.021.Secreted
Deneris ES (2011) Molecular genetics of mouse serotonin neurons
across the lifespan. Neuroscience 197:17–27. doi:10.1016/j.
neuroscience.2011.08.061
Depuy SD, Kanbar R, Coates MB et al (2011) Control of breathing by
raphe obscurus serotonergic neurons in mice. J Neurosci
31:1981–1990. doi:10.1523/JNEUROSCI.4639-10.2011
DePuy SD, Stornetta RL, Bochorishvili G et al (2013) Glutamatergic
neurotransmission between the C1 neurons and the parasympa-
thetic preganglionic neurons of the dorsal motor nucleus of the
vagus. J Neurosci 33:1486–1497. doi:10.1523/JNEUROSCI.
4269-12.2013
Dorph-Petersen KA, Nyengaard JR, Gundersen HJG (2001) Tissue
shrinkage and unbiased stereological estimation of particle
number and size. J Microsc 204:232–246. doi:10.1046/j.1365-
2818.2001.00958.x
Dos Santos L, De Andrade TGCS, Zangrossi H (2005) Serotonergic
neurons in the median raphe nucleus regulate inhibitory avoid-
ance but not escape behavior in the rat elevated T-maze test of
anxiety. Psychopharmacology 179:733–741. doi:10.1007/
s00213-004-2120-3
Dulcis D, Jamshidi P, Leutgeb S, Spitzer NC (2013) Neurotransmitter
switching in the adult brain regulates behavior. Science
340:449–453. doi:10.1126/science.1234152
Fox SR, Deneris ES (2012) Engrailed is required in maturing
serotonin neurons to regulate the cytoarchitecture and survival of
the dorsal raphe nucleus. J Neurosci 32:7832–7842. doi:10.1523/
JNEUROSCI.5829-11.2012
Fremeau RT, Burman J, Qureshi T et al (2002) The identification of
vesicular glutamate transporter 3 suggests novel modes of
signaling by glutamate. Proc Natl Acad Sci USA
99:14488–14493. doi:10.1073/pnas.222546799
Gras C, Herzog E, Bellenchi GC et al (2002) A third vesicular
glutamate transporter expressed by cholinergic and serotoniner-
gic neurons. J Neurosci 22:5442–5451
Gundersen HJG (1986) Stereology of arbitrary shaped particles:
unbiased estimation of number and size. Science on form. In:
Proceeding of the first international symposium for science on
form, pp 509–516
Gutie´rrez R, Romo-Parra H, Maqueda J et al (2003) Plasticity of the
GABAergic phenotype of the ‘‘glutamatergic’’ granule cells of
the rat dentate gyrus. J Neurosci 23:5594–5598
Hawthorne AL, Wylie CJ, Landmesser LT et al (2010) Serotonergic
neurons migrate radially through the neuroepithelium by
dynamin-mediated somal translocation. J Neurosci 30:420–430.
doi:10.1523/JNEUROSCI.2333-09.2010
Hendricks T, Francis N, Fyodorov D, Deneris ES (1999) The ETS
domain factor Pet-1 is an early and precise marker of central
serotonin neurons and interacts with a conserved element in
serotonergic genes. J Neurosci 19:10348–10356
Hendricks TJ, Fyodorov DV, Wegman LJ et al (2003) Pet-1 ETS gene
plays a critical role in 5-HT neuron development and is required
for normal anxiety-like and aggressive behavior. Neuron
37:233–247. doi:10.1016/S0896-6273(02)01167-4
Hensler JG (2006) Serotonergic modulation of the limbic system.
Neurosci Biobehav Rev 30:203–214. doi:10.1016/j.neubiorev.
2005.06.007
Hioki H, Nakamura H, Ma YF et al (2010) Vesicular glutamate
transporter 3-expressing nonserotonergic projection neurons
constitute a subregion in the rat midbrain raphe nuclei. J Comp
Neurol 518:668–686. doi:10.1002/cne.22237
Hodges MR, Wehner M, Aungst J et al (2009) Transgenic mice
lacking serotonin neurons have severe apnea and high mortality
during development. J Neurosci 29:10341–10349. doi:10.1523/
JNEUROSCI.1963-09.2009
Jackson J, Bland BH, Antle MC (2009) Nonserotonergic projection
neurons in the midbrain raphe nuclei contain the vesicular
glutamate transporter VGLUT3. Synapse 63:31–41. doi:10.1002/
syn.20581
Jahanshahi A, Steinbusch HWM, Temel Y (2013) Distribution of
dopaminergic cell bodies in the median raphe nucleus of the rat
brain. J Chem Neuroanat 53:60–63. doi:10.1016/j.jchemneu.
2013.09.002
Kinney GG, Kocsis B, Vertes RP (1996) Medial septal unit firing
characteristics following injections of 8-OH-DPAT into the
median raphe nucleus. Brain Res 708:116–122
Kiyasova V, Fernandez SP, Laine J et al (2011) A genetically defined
morphologically and functionally unique subset of 5-HT neurons
in the mouse raphe nuclei. J Neurosci 31:2756–2768. doi:10.
1523/JNEUROSCI.4080-10.2011
Ko¨hler CC-PV (1982) Somatostatin-like immunoreactive neurons in
the hippocampus: an immunocytochemical study in the rat.
Neurosci Lett 34:259–264
Liu C, Maejima T, Wyler SC et al (2010) Pet-1 is required across
different stages of life to regulate serotonergic function. Nat
Neurosci 13:1190–1198. doi:10.1038/nn.2623
Madisen L et al (1993) Regulation of fatty acid synthase gene
expression: an approach for reducing fat accumulation. J Anim
Sci 71:1957–1965. doi:10.1038/nn.2467
Mintz EM, Scott TJ (2006) Colocalization of serotonin and vesicular
glutamate transporter 3-like immunoreactivity in the midbrain
raphe of Syrian hamsters (Mesocricetus auratus). Neurosci Lett
394:97–100. doi:10.1016/j.neulet.2005.10.033
Mullen RJ, Buck CR, Smith AM (1992) NeuN, a neuronal specific
nuclear protein in vertebrates. Development 116:201–211
Ohmura Y, Tanaka KF, Tsunematsu T et al (2014) Optogenetic
activation of serotonergic neurons enhances anxiety-like beha-
viour in mice. Int J Neuropsychopharmacol. doi:10.1017/
S1461145714000637
Paxinos, G and Franklin KBJ (2012) Paxinos and Franklin’s the
mouse brain in stereotaxic coordinates, 4th edn, Academic Press,
ISBN:9780123910578
Pelosi B, Migliarini S, Pacini G et al (2014) Generation of Pet1210-
Cre transgenic mouse line reveals non-serotonergic expression
domains of Pet1 both in CNS and periphery. PLoS One
9:e104318. doi:10.1371/journal.pone.0104318
Peters S, Slattery DA, Uschold-Schmidt N et al (2014) Dose-
dependent effects of chronic central infusion of oxytocin on
anxiety, oxytocin receptor binding and stress-related parameters
in mice. Psychoneuroendocrinology 42:225–236. doi:10.1016/j.
psyneuen.2014.01.021
Rind HB, Russo AF, Whittemore SR (2000) Developmental regula-
tion of tryptophan hydroxylase messenger RNA expression and
enzyme activity in the raphe and its target fields. Neuroscience
101:665–677. doi:10.1016/S0306-4522(00)00402-4
Schmitz C, Hof PR (2005) Design-based stereology in neuroscience.
Neuroscience 130:813–831. doi:10.1016/j.neuroscience.2004.08.
050
Brain Struct Funct
123
Scott MM, Wylie CJ, Lerch JK et al (2005) A genetic approach to
access serotonin neurons for in vivo and in vitro studies. Proc
Natl Acad Sci USA 102:16472–16477. doi:10.1073/pnas.
0504510102
Serrats J, Artigas F, Mengod G, Corte´s R (2003) GABA B receptor
mRNA in the raphe nuclei: co-expression with serotonin
transporter and glutamic acid decarboxylase. J Neurochem
84:743–752. doi:10.1046/j.0022-3042.2003.01557.x
Shutoh F, Ina A, Yoshida S et al (2008) Two distinct subtypes of
serotonergic fibers classified by co-expression with vesicular
glutamate transporter 3 in rat forebrain. Neurosci Lett
432:132–136. doi:10.1016/j.neulet.2007.12.050
Silva RCB, Ga´rgaro AC, Branda˜o ML (2004) Differential regulation
of the expression of contextual freezing and fear-potentiated
startle by 5-HT mechanisms of the median raphe nucleus. Behav
Brain Res 151:93–101. doi:10.1016/j.bbr.2003.08.015
Somogyi J, Baude A, Omori Y et al (2004) GABAergic basket cells
expressing cholecystokinin contain vesicular glutamate trans-
porter type 3 (VGLUT3) in their synaptic terminals in
hippocampus and isocortex of the rat. Eur J Neurosci
19:552–569. doi:10.1111/j.0953-816X.2003.03091.x
Spaethling JM, Piel D, Dueck H et al (2014) Serotonergic neuron
regulation informed by in vivo single-cell transcriptomics.
FASEB J 28:771–780. doi:10.1096/fj.13-240267
Stamp JA, Semba K (1995) Extent of colocalization of serotonin and
GABA in the neurons of the rat raphe nuclei. Brain Res 677:39–49
Sterio D (1984) The unbiased estimation of number and sizes of
arbitrary particles using the disector. J Microsc 134:127–136
Sz}onyi A, Mayer MI, Csere´p C et al (2014) The ascending median
raphe projections are mainly glutamatergic in the mouse
forebrain. Brain Struct Funct. doi:10.1007/s00429-014-0935-1
Varga V, Losonczy A, Zemelman BV et al (2009) Fast synaptic
subcortical control of hippocampal circuits. Science
326:449–453. doi:10.1126/science.1178307
Vertes RP, Kocsis B (1997) Brainstem-diencephalo-septohippocam-
pal systems controlling the theta rhythm of the hippocampus.
Neuroscience 81:893–926
Vertes RP, Fortin WJ, Crane AM (1999) Projections of the median
raphe nucleus in the rat. J Comp Neurol 407:555–582. doi:10.
1002/(SICI)1096-9861(19990517)407:4\555:AID-CNE7[3.3.
CO;2-5
Vong L, Ye C, Yang Z et al (2011) Leptin action on GABAergic
neurons prevents obesity and reduces inhibitory tone to POMC
neurons. Neuron 71:142–154. doi:10.1016/j.neuron.2011.05.028
Wang DV, Yau HJ, Broker CJ, Tsou JH, Bonci AIS (2015)
Mesopontine median raphe regulates hippocampal ripple oscil-
lation and memory consolidation. Nat Neurosci 18:728–735.
doi:10.1038/nn.3998
West MJ, Slomianka LGH (1991) Unbiased stereological estimation
of the total number of neurons in the subdivisions of the rat
hippocampus using the optical fractionator. Anat Rec
231:482–497. doi:10.1002/ar.1092310411
Yizhar O, Fenno LE, Davidson TJ et al (2011) Optogenetics in neural
systems. Neuron 71:9–34. doi:10.1016/j.neuron.2011.06.004
Zangrossi H, Graeff FG (2014) Serotonin in anxiety and panic:
contributions of the elevated T-maze. Neurosci Biobehav Rev
46:397–406. doi:10.1016/j.neubiorev.2014.03.007
Brain Struct Funct
123
